根据Aon报告,亚太医疗计划费用在2026年将增长11.3%,原因是慢性病和药物价格。 Asia Pacific medical plan costs to rise 11.3% in 2026, driven by chronic illness and drug prices, per Aon report.

根据Aon的《2026年全球医疗趋势报告》,亚洲太平洋雇员医疗计划费用预计2026年将上升11.3%,经过两年的急剧增长后稳定下来。 Asia Pacific employee medical plan costs are projected to rise 11.3% in 2026, stabilizing after two years of steep increases, according to Aon’s 2026 Global Medical Trend Rates Report. 预计全球平均水平为9.8%。 The global average is expected at 9.8%. 中国、印度、新加坡、菲律宾和越南等关键市场的增长可能较低,因为保健利用率降低,福利举措增加。 Key markets like China, India, Singapore, the Philippines, and Vietnam may see lower increases due to reduced healthcare utilization and growing wellbeing initiatives. 心血管疾病、胃肠病和癌症仍然是成本最高的驱动因素,由慢性疾病、药物成本上升和医疗技术所助长。 Cardiovascular diseases, gastrointestinal conditions, and cancer remain top cost drivers, fueled by chronic illness, rising drug costs, and medical technology. 雇主正在采用灵活的好处、成本控制和针对无活动、压力和新陈代谢风险的预防计划。 Employers are adopting flexible benefits, cost controls, and prevention programs targeting inactivity, stress, and metabolic risks. Aon敦促战略规划、数据使用和地方招标,以便在不断演变的保健需求中维持效益。 Aon urges strategic planning, data use, and local tendering to sustain benefits amid evolving healthcare demands.